Position statement for management of genitourinary syndrome of the menopause (GSM)

One of the most consistently identified predictors of impaired sexual health in women is the presence of vaginal symptoms. Up to 84% of postmenopausal women have symptoms associated with Genitourinary Syndrome of the Menopause (GSM) yet only a minority receive any treatment. Unlike many other symptoms of the menopause, symptoms of GSM often worsen over time.
This guidance is designed to support healthcare professionals in diagnosing and managing this condition, including in those with a history of cancer.